Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,157 | 62,513 | 69,204 | 86,522 | 34,906 |
| Receivables | 31,319 | 36,732 | 26,519 | 15,505 | 20,902 |
| Inventories | 163,116 | 161,780 | 163,985 | 163,280 | 162,914 |
| TOTAL | $273,699 | $266,243 | $264,086 | $270,402 | $224,095 |
| Non-Current Assets | |||||
| PPE Net | 54,815 | 56,306 | 57,371 | 58,261 | 56,946 |
| Intangibles | 4,006 | 4,185 | 4,364 | 4,543 | 4,722 |
| Other Non-Current Assets | 16,477 | 16,293 | 14,966 | 15,255 | 14,795 |
| TOTAL | $75,298 | $76,784 | $76,701 | $78,059 | $76,463 |
| Total Assets | $348,997 | $343,027 | $340,788 | $348,461 | $300,558 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,852 | 12,085 | 12,957 | 13,229 | 25,198 |
| Accrued Expenses | 29,864 | 28,746 | 22,673 | 24,990 | 18,379 |
| TOTAL | $41,841 | $41,953 | $36,728 | $39,267 | $44,440 |
| Non-Current Liabilities | |||||
| Long Term Debt | 142,026 | 140,312 | 144,301 | 142,833 | 141,366 |
| Deferred Revenues | 143 | 143 | 143 | 143 | 143 |
| Other Non-Current Liabilities | 2,002 | 2,017 | 1,839 | 1,850 | 1,862 |
| TOTAL | $155,718 | $154,312 | $158,405 | $157,220 | $155,733 |
| Total Liabilities | $197,559 | $196,265 | $195,133 | $196,487 | $200,173 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 225,968 | 224,906 | 222,273 | 222,156 | 196,777 |
| Common Shares | 23 | 23 | 22 | 22 | 20 |
| Retained earnings | -488,611 | -491,176 | -484,806 | -478,017 | -465,785 |
| TOTAL | $151,437 | $146,762 | $145,655 | $151,974 | $100,385 |
| Total Liabilities And Equity | $348,997 | $343,027 | $340,788 | $348,461 | $300,558 |